The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Last updated: July 23, 2024
Sponsor: Shanghai Dermatology Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Allergies & Asthma

Allergy (Pediatric)

Allergy

Treatment

bFGF

Bovine Basic Gel

Clinical Study ID

NCT06516939
2024-06
  • Ages 18-60
  • All Genders

Study Summary

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Sensitive skin with a diagnosis of persistent erythema and a lactate irritation testscore of 2-3

  2. No related skin care products including bovine alkaline fibroblast growth factorwere used within 1 month before participating in the experiment, and photoelectrictreatment measures were not carried out

  3. Physical sunscreen should be strict during enrollment

Exclusion

Exclusion Criteria:

  1. Children

  2. Have serious heart, liver, kidney, and blood system diseases, and severeimmunocompromise

  3. Patients with mental illness or cancer

  4. Those who have received glucocorticoids, calcineurin inhibitors, topical smallmolecule drugs, antibiotics or tretinoin within 3 months

  5. Those who are allergic to basic fibroblast growth factor gel and its components

  6. Acute dermatitis of the face and perifolliculitis

Study Design

Total Participants: 28
Treatment Group(s): 2
Primary Treatment: bFGF
Phase:
Study Start date:
June 10, 2024
Estimated Completion Date:
July 18, 2024

Connect with a study center

  • Shanghai Skin Disease Hospital

    Shanghai,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.